Bank of New York Mellon Corp - APTEVO THERAPEUTICS INC ownership

APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 28 filers reported holding APTEVO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of APTEVO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$41,829
-12.3%
20,5550.0%0.00%
Q4 2022$47,688
-24.3%
20,555
-0.7%
0.00%
Q3 2022$63,000
-14.9%
20,6970.0%0.00%
Q2 2022$74,000
-51.3%
20,697
-20.2%
0.00%
Q1 2022$152,000
-50.2%
25,952
+160.5%
0.00%
Q1 2021$305,0009,9640.00%
Other shareholders
APTEVO THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,760,000$64,504,0009.85%
Stonepine Capital Management, LLC 18,280$670,0000.51%
Ghost Tree Capital, LLC 50,000$1,833,0000.41%
Anson Funds Management LP 45,462$1,666,0000.34%
RTW INVESTMENTS, LP 288,236$10,564,0000.18%
Dynamic Technology Lab Private Ltd 13,202$484,0000.08%
Alyeska Investment Group, L.P. 49,601$1,818,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 11,493$421,0000.02%
PURA VIDA INVESTMENTS, LLC 8,203$301,0000.01%
Renaissance Technologies 254,423$9,325,0000.01%
View complete list of APTEVO THERAPEUTICS INC shareholders